Every 424B that Bakkt, Inc. (BKKT) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow BKKT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BKKT filings page.
Bakkt, Inc. is registering the offer and resale of up to 21,010,640 shares of Class A Common Stock for the selling stockholders named in the prospectus, including shares issued in connection with the DTR Acquisition, the Up-C collapse and the Gyzer acquisition. The resale is by selling stockholders in their sole discretion; the Company will receive no proceeds from resales (except potential cash proceeds if certain warrants are exercised). As of April 30, 2026, there were 47,866,956 shares outstanding. The registration implements contractual registration rights granted in connection with the DTR Acquisition and related agreements.
Bakkt, Inc. is offering 3,024,799 shares of Class A common stock and pre-funded warrants to purchase 2,475,201 shares. The offering price is $8.75 per share and $8.7499 per Pre-Funded Warrant, with an exercise price of $0.0001 per share for the Pre-Funded Warrants.
The Securities are being sold to a single investor under a purchase agreement dated February 27, 2026, with delivery expected on or around March 2, 2026. Net proceeds are estimated at approximately $45.4 million and Bakkt intends to use proceeds for working capital, general corporate purposes and strategic initiatives. Shares outstanding after the offering are based on 27,537,293 shares as of February 26, 2026.
Bakkt Holdings, Inc. plans an at-the-market offering of up to $300,000,000 of its Class A common stock under a new sales agreement with multiple sales agents. Shares may be sold from time to time on the NYSE or through other permitted methods at prevailing, related or negotiated prices, with agents earning commissions of up to 3% of the gross sales price.
The company expects to use any net proceeds for working capital and general corporate purposes. Bakkt notes that issuing new shares will dilute existing holders; there were 25,529,359 shares of common stock outstanding as of January 14, 2026. An illustrative example in the filing shows the impact on book value and per-share dilution if the full $300,000,000 is raised. The document also highlights that additional share issuances, including potential stock consideration for the proposed DTR Acquisition if approved by shareholders, could further dilute investors and that the stock has experienced significant price volatility.